| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.07 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.07 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.32 | 0.07 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.059 | 0.07 |